Nsaids Gastropathy/Dyspepsia Upon Chronic Gastritis In Anamnesis In Patients With Osteoarthrosis
M. Y. Zak, L. M. Pasiyeshvili, M. Y. Knysh
Index Terms: Chronic Gastritis, NSAIDs Gastropathy, NSAIDs Dyspepsia.
Abstract: 122 patients with osteoarthrosis, who had verified chronic gastritis in the anamnesis (50 males and 72 females), aged from 42 to 64, were examined. Control group included 40 patients with osteoarthrosis without gastroduodenal zone pathology in the anamnesis. For arthralgia relief, patients were prescribed to intake meloxicam (average dose — 12.5±1.39 mg/day) or nimesulide (average dose — 150±14.91 mg/day). As a result of this research, it was determined that prescription of selective NSAIDs (meloxicam and nimesulide) raised the risk of NSAIDs gastropathy/dyspepsia in 2.9 times (P<0.03) in patients with chronic gastritis in the anamnesis than in patients without associated gastroduodenal zone pathology. Atrophy of gastric mucous membrane was associated with higher risks (P>0.05) of erosive gastropathy. With the purpose of gastropathy prevention upon taking NSAIDs, patients with chronic gastritis in the anamnesis are recommended to undergo gastroprotective therapy.
 F.L. Lanza, F.K. Chan, E.M. Quigley, and Practice Parameters Committee of the American College of Gastroenterology, “Guidelines for Prevention of NSAID-Related Ulcer Complications”, Am. J. Gastroenterol., vol. 104, no. 3, pp. 728-738, Mar. 2009.
 M.Y. Zak and L.M. Mosiychuk, Chronic Gastritis and Gastric Precancer: Textbook. Dnepropetrovsk, 2011.
 A.Y. Karateev, “Nimesulide: Issues of Safety and Opportunities of Prolonged Intake” [“Нимесулид: Вопросы Безопасности и Возможность Длительного Применения”], Pharmateka, vol. 4, pp. 17-25, 2009.
 V.M. Kovalenko, Osteoarthrosis. Practical Guidelines. Kiev: Morion, 2010.
 M.F. Dixon, R.M. Genta, J.H. Yardley, and P. Correa, “Classification and Grading of Gastritis. The Updated Sydney System International Workshop on the Histopathology of Gastritis, Houston 1994”, Am. J. Surg. Pathol., vol. 20, no. 10, pp. 1161-1181, Oct. 1996.
 M. Rugge, M. de Boni, G. Pennelli, M. de Bona, L. Giacomelli, M. Fassan, D. Basso, M. Plebani, and D.Y. Graham, “Gastritis OLGA-Staging and Gastric Cancer Risk: a Twelve-Year Clinico-Pathological Follow-Up Study”, Minerva Gastroenterol. Dietol., vol. 56, no. 1, pp. 13-17, May 2010.